|
| View:
Latest News | Top Stories |
|
| 1.
|
Emisphere Technologies Announces Financial and Operational Results for the Third Quarter and First Nine Months of 2009
-
Business Wire
-
2 hours, 42 minutes ago
CEDAR KNOLLS, N.J.----Emisphere Technologies, Inc. today announced financial and operational results for the third quarter and nine months ended September 30, 2009.
|
|
| 2.
|
"CRINONE® 8% (progesterone vaginal gel) As Effective as Hormone Injections During IVF" Is Medscape's "Top News" from The ASRM 65th Annual Meeting
-
Business Wire
-
Mon 8:00 am ET
LIVINGSTON, N.J.----In their American Society of Reproductive Medicine conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections for luteal support in infertility treatment.
|
|
| 3.
|
Recalls: Anesthetic medications
-
AP
-
Fri Nov 6
The following recall has been announced: Hospira Inc., a global specialty pharmaceutical and medication delivery company, is voluntarily recalling certain anesthetics because of possible contamination.
|
|
| 4.
|
NovaDel Receives Notice of Allowance for New U.S. Patent Covering its Oral Spray Drug Delivery Technology
-
Business Wire
-
Thu Nov 5
FLEMINGTON, N.J.----NovaDel Pharma Inc. , today announced that it received a Notice of Allowance from the United States Patent and Trademark Office for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.
|
|
| 5.
|
Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call
-
Business Wire
-
Wed Nov 4
LYON, France----Flamel Technologies expects to release its financial results for the third quarter of 2009 the morning of November 16th, before the market opening. A conference call to discuss the results has been scheduled for Monday, November 16th, at 8:30 AM .
|
|
| 6.
|
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
-
PR Newswire
-
Wed Nov 4
Nektar Therapeutics today reported its financial results for the third quarter ended September 30, 2009.
|
|
| 7.
|
Emisphere Technologies Announces Third Quarter 2009 Conference Call
-
Business Wire
-
Wed Nov 4
CEDAR KNOLLS, N.J.----Emisphere Technologies, Inc. announced today that management will host a conference call to discuss the Company’s financial and operational results for the third quarter ended September 30, 2009 on Monday, November 9, 2009 at 10:00 AM EST.
|
|
| 8.
|
Generex's Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio
-
GlobeNewswire
-
Mon Nov 2
WORCESTER, Mass. -- Bill Abajian, Senior Executive Advisor for Global Licensing and Business Development for Generex Biotechnology Corporation , is featured on the Doggie Chronicles Radio Program -- "a show all about dogs and the people who love them."
|
|
| 9.
|
Generex Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice
-
GlobeNewswire
-
Thu Oct 29
WORCESTER, Mass. -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that, in light of general market conditions, Generex will not exercise its right to issue and sell shares of its common stock under the At Market Issuance Sales Agreement that it entered into with Wm Smith & Co. on October 14, 2009 until further notice.
|
|
| 10.
|
Delcath Systems, Inc. Announces Public Offering of Common Stock
-
PR Newswire
-
Tue Oct 27
Delcath Systems, Inc. announced today that it intends, subject to market and other conditions, to offer up to 8.5 million shares of its common stock in a registered public offering pursuant to its existing shelf registration statement under the Securities Act of 1933.
|
|
